Chouhan

"The sector is looking cheap on a five-year view," says Naresh Chouhan , European pharmaceutical analyst at London investment bank Liberum Capital.

Pharma Edges Toward 'Patent Cliff' Sten Stovall 2011

However, leaders such as Nitish Kumar, Naveen Patnaik, Shivraj Chouhan and Narendra Modi have proven that you need not have always run a state to provide good governance.

The Anti-Communist of West Bengal 2011

A partnership with Poland's Polpharma SA to jointly develop and sell a range of drug ingredients will start contributing to sales early in the next financial year, Mr. Chouhan said.

RPG Life Sciences Expects Growth Spurt in 2013 Rumman Ahmed 2011

However, the issue is that we've got these big patent expiries in 2012 and 2013, and the shorter-term investors aren't willing to look past that yet, Mr. Chouhan says.

Pharma Edges Toward 'Patent Cliff' Sten Stovall 2011

The small-sized drug maker expects to launch 20 new products in India and between two and four drug ingredients globally this year, Mr. Chouhan added.

RPG Life Sciences Expects Growth Spurt in 2013 Rumman Ahmed 2011

RPG Life is registering its generic drugs in Germany and sales will start once the process is completed by January-March 2012 and its local partners win supply tenders, Mr. Chouhan said.

RPG Life Sciences Expects Growth Spurt in 2013 Rumman Ahmed 2011

"The sector is looking cheap on a five-year view," says Naresh Chouhan , European pharmaceutical analyst at London investment bank Liberum Capital.

Pharma Edges Toward 'Patent Cliff' Sten Stovall 2011

However, the issue is that we've got these big patent expiries in 2012 and 2013, and the shorter-term investors aren't willing to look past that yet, Mr. Chouhan says.

Pharma Edges Toward 'Patent Cliff' Sten Stovall 2011

It has a capital expenditure outlay of 600 million rupees-700 million rupees for the current and next fiscal years, Mr. Chouhan said.

RPG Life Sciences Expects Growth Spurt in 2013 Rumman Ahmed 2011

It is aiming to grow both profit and sales by about 15% in the current financial year, driven by sales of bulk drugs globally and branded generic drugs locally, managing director Ajit Singh Chouhan said recently.

RPG Life Sciences Expects Growth Spurt in 2013 Rumman Ahmed 2011